Incorporating of herd immunity into pharmacoeconomic evaluation of pneumococcal conjugate vaccine PNC-7

被引：1
|
作者：
Claes, C
Reinert, RR
Schulenburg, JM
机构：
[1] Univ Hannover, Hannover, Germany
[2] Inst Med Microbiol, Aachen, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62761-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INCLUDING HERD PROTECTION IN TURKEY
    Turel, O.
    McIntosh, D.
    Bakir, M.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A436 - A436
  • [22] IMMUNOGENICITY OF PENTAVALENT PNEUMOCOCCAL (PNC) CONJUGATE VACCINE IN FINNISH 2-YEAR-OLD CHILDREN
    KAYHTY, H
    NIEMINEN, T
    AHMAN, H
    MALINOSKI, FJ
    ESKOLA, J
    [J]. PEDIATRIC RESEARCH, 1994, 35 (04) : A183 - A183
  • [23] Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
    Jayasinghe, Sanjay
    Chiu, Clayton
    Menzies, Rob
    Lehmann, Deborah
    Cook, Heather
    Giele, Carolien
    Krause, Vicki
    McIntyre, Peter
    [J]. VACCINE, 2015, 33 (48) : 6666 - 6674
  • [24] The impact of indirect (Herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine
    Isaacman, Daniel J.
    Strutton, David R.
    Kalpas, Edward A.
    Horowicz-Mehler, Nathalie
    Stern, Lee S.
    Casciano, Roman
    Ciuryla, Vincent
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (02) : 341 - 357
  • [25] Immunisation with a pneumococcal 7-valent conjugate vaccine
    Dagan, R
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (04) : 287 - 291
  • [26] From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy
    Linares-Perez, Nivaldo
    Toledo-Romani, Maria E.
    Santana-Mederos, Darielys
    Garcia-Farinas, Anai
    Garcia-Rivera, Dagmar
    Valdes-Balbin, Yury
    Verez-Bencomo, Vicente
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 60 : 98 - 102
  • [27] Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
    Kristiansen, Paul A.
    Diomande, Fabien
    Ba, Absatou Ky
    Sanou, Idrissa
    Ouedraogo, Abdoul-Salam
    Ouedraogo, Rasmata
    Sangare, Lassana
    Kandolo, Denis
    Ake, Flavien
    Saga, Inger Marie
    Clark, Thomas A.
    Misegades, Lara
    Martin, Stacey W.
    Thomas, Jennifer Dolan
    Tiendrebeogo, Sylvestre R.
    Hassan-King, Musa
    Djingarey, Mamoudou H.
    Messonnier, Nancy E.
    Preziosi, Marie-Pierre
    LaForce, F. Marc
    Caugant, Dominique A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 354 - 363
  • [28] Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
    van Deursen, Anna M. M.
    van Mens, Suzan P.
    Sanders, Elisabeth A. M.
    Vlaminckx, Bart J. M.
    de Melker, Hester E.
    Schouls, Leo M.
    de Greeff, Sabine C.
    van der Ende, Arie
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (11) : 1729 - 1737
  • [29] Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance
    Pletz, M. W.
    Maus, U.
    Hohlfeld, J. M.
    Lode, H.
    Welte, T.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (08) : 358 - 362
  • [30] Pharmacoeconomic evaluation of 10-and 13-valent pneumococcal conjugate vaccines
    Chuck, Anderson W.
    Jacobs, Philip
    Tyrrell, Gregory
    Kellner, James D.
    [J]. VACCINE, 2010, 28 (33) : 5485 - 5490
12345